Cargando…
Prospective Evaluation of Single Nucleotide Variants by Two Different Technologies in Paraffin Samples of Advanced Non-Small Cell Lung Cancer Patients
Targeted therapies are a new paradigm in lung cancer management. Next-generation sequencing (NGS) techniques have allowed for simultaneous testing of several genes in a rapid and efficient manner; however, there are other molecular diagnostic tools such as the nCounter(®) Vantage 3D single nucleotid...
Autores principales: | Marin, Elba, Reyes, Roxana, Arcocha, Ainara, Viñolas, Nuria, Mezquita, Laura, Gonzalvo, Elena, Saez de Gordoa, Karmele, Jares, Pedro, Reguart, Noemi, Teixido, Cristina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7693424/ https://www.ncbi.nlm.nih.gov/pubmed/33153192 http://dx.doi.org/10.3390/diagnostics10110902 |
Ejemplares similares
-
182P Impact of SARS CoV 2 outbreak in the molecular diagnosis of advanced NSCLC: A retrospective comparative cohort study
por: Marin, E., et al.
Publicado: (2021) -
A Pilot Study to Evaluate Early Predictive Value of Thorax Perfusion-CT in Advanced NSCLC
por: Aya, Francisco, et al.
Publicado: (2021) -
Molecular characterization of advanced non-small cell lung cancer patients by cfDNA analysis: experience from routine laboratory practice
por: González de Aledo-Castillo, José Manuel, et al.
Publicado: (2021) -
Usefulness of Two Independent DNA and RNA Tissue-Based Multiplex Assays for the Routine Care of Advanced NSCLC Patients
por: Marin, Elba, et al.
Publicado: (2020) -
EBUS-TBNA Cytological Samples for Comprehensive Molecular Testing in Non–Small Cell Lung Cancer
por: Martin-Deleon, Roberto, et al.
Publicado: (2021)